Skip to main content

Autolus Therapeutics plc

AUTL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001730463

In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 91 institutions reported holding it in 13F filings for Q3 2026, worth $254.2M in total; no superinvestor holds it.

Holders of 5% or more of AUTL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Autolus Therapeutics plc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of AUTL
HolderLatest formStakeChangeFirst filedLatest filingFiling
MAK Capital Fund LP13G/A11.50%30.5M shares−1.10 ppfrom 12.60%Jun 25, 20255 filingsNov 16, 2026SEC
Syncona Portfolio Ltd13G/A10.80%28.8M shares–Feb 12, 20216 filingsMay 7, 2025SEC
Blackstone Group Inc.13D/A7.60%20.5M shares–Nov 16, 20214 filingsNov 10, 2026SEC
PPF Group a.s.13D/A5.60%14.8M shares–Oct 25, 20242 filingsAug 28, 2026SEC
Armistice Capital, LLC13G/A5.17%13.8M shares−0.47 ppfrom 5.64%Feb 14, 20237 filingsNov 16, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

53 Schedule 13D and 13G filings on Autolus Therapeutics plc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on AUTL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 20264:01 PM ETMAK Capital Fund LPand 2 others13G/A11.50%30.5M shares−1.10 ppfrom 12.60%Sep 30, 2026SEC
Nov 16, 202612:00 PM ETArmistice Capital, LLCand 1 other13G/A5.17%13.8M shares−0.47 ppfrom 5.64%Sep 30, 2026SEC
Nov 12, 20266:43 AM ETQatar Investment Authority13G/A3.50%9.18M shares–Below 5%Sep 30, 2026SEC
Nov 10, 20264:30 PM ETBlackstone Group Inc.and 7 others13D/A7.60%20.5M shares–Nov 6, 2026SEC
Aug 28, 20269:08 PM ETPPF Group a.s.and 3 others13D/A5.60%14.8M shares–Aug 27, 2026SEC
Aug 14, 202610:01 AM ETArmistice Capital, LLCand 1 other13G/A5.64%15.0M shares−0.30 ppfrom 5.94%Jun 30, 2026SEC
May 15, 20263:04 PM ETMAK Capital Fund LPand 2 others13G/A12.60%33.6M shares+1.30 ppfrom 11.30%Mar 31, 2026SEC
May 15, 202611:06 AM ETArmistice Capital, LLCand 1 other13G/A5.94%15.8M shares−0.64 ppfrom 6.58%Mar 31, 2026SEC
Feb 17, 20269:51 PM ETArmistice Capital, LLCand 1 other13G/A6.58%17.5M shares+0.72 ppfrom 5.86%Dec 31, 2025SEC
Feb 13, 20264:07 PM ETMAK Capital Fund LPand 2 others13G/A11.30%30.0M shares+1.20 ppfrom 10.10%Dec 31, 2025SEC
Dec 3, 20254:04 PM ETMAK Capital Fund LPand 2 others13G/A10.10%26.9M shares+4.30 ppfrom 5.80%Dec 1, 2025SEC
Nov 14, 20256:38 PM ETArmistice Capital, LLCand 1 other13G5.86%15.6M shares–Sep 30, 2025SEC
Nov 14, 20258:08 AM ETDeep Track Capital, LPand 2 others13G/A0.97%2.57M shares–Below 5%Sep 30, 2025SEC
Oct 6, 202512:22 PM ETWellington Management Group LLPand 2 others13G/A0.00%0 shares−10.20 ppfrom 10.20%Below 5%Sep 30, 2025SEC
Jun 25, 20256:36 PM ETMAK Capital Fund LPand 2 others13G5.80%15.4M sharesNewJun 17, 2025SEC
May 12, 202510:24 AM ETFMR LLCand 1 other13G/A3.80%10.2M shares–Below 5%Mar 31, 2025SEC
May 7, 20259:00 AM ETSyncona Portfolio Ltdand 6 others13G/A10.80%28.8M shares–Mar 31, 2025SEC
Apr 4, 20259:46 AM ETWellington Management Group LLPand 3 others13G/A10.20%27.1M shares–Mar 31, 2025SEC
Nov 14, 2024Syncona Portfolio Ltd13G/AOld format–––SEC
Nov 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Nov 14, 2024Paradigm Biocapital Advisors LP13G/AOld format–––SEC
Nov 12, 2024FMR LLC13GOld format–New–SEC
Nov 8, 2024Wellington Management Group LLP13GOld format–New–SEC
Oct 25, 2024PPF Group N.V.13D/AOld format–––SEC
May 21, 20244:30 PM ETBlackstone Group Inc.13D/AOld format–––SEC
Mar 25, 2024Kellnerova Renata13D/AOld format–––SEC
Feb 21, 20245:01 PM ETBioNTech SE13DOld format–New–SEC
Feb 14, 2024Armistice Capital, LLC13G/AOld format–––SEC
Feb 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Feb 14, 2024Paradigm Biocapital Advisors LP13G/AOld format–––SEC
Feb 13, 2024Syncona Portfolio Ltd13G/AOld format–––SEC
Jan 31, 2024Tetragon Financial Management LP13G/AOld format–––SEC
Jul 10, 2023Paradigm Biocapital Advisors LP13GOld format–New–SEC
Mar 20, 2023Tetragon Financial Management LP13GOld format–New–SEC
Feb 14, 2023Frazier Life Sciences Public Fund, L.P.13G/AOld format–––SEC
Feb 14, 2023Syncona Portfolio Ltd13G/AOld format–––SEC
Feb 14, 2023Armistice Capital, LLC13GOld format–New–SEC
Feb 14, 2023Deep Track Capital, LP13G/AOld format–––SEC
Feb 14, 2023Nantahala Capital Management, LLC13G/AOld format–––SEC
Feb 13, 2023Capital World Investors13G/AOld format–––SEC
Dec 19, 2022Deep Track Capital, LP13GOld format–New–SEC
Dec 13, 20224:51 PM ETBlackstone Group Inc.13D/AOld format–––SEC
Dec 13, 2022Qatar Investment Authority13GOld format–New–SEC
Oct 5, 2022PPF Biotech B.V.13D/AOld format–––SEC
Feb 14, 2022Nantahala Capital Management, LLC13GOld format–New–SEC
Feb 11, 2022Syncona Portfolio Ltd13G/AOld format–––SEC
Dec 17, 2021Frazier Life Sciences Public Fund, L.P.13GOld format–New–SEC
Nov 16, 20214:07 PM ETBlackstone Group Inc.13DOld format–New–SEC
Jun 23, 2021PPF Capital Partners Fund B.V.13D/AOld format–––SEC
Feb 17, 2021Arix Bioscience plc13D/AOld format–––SEC

Form 144: proposed insider sales

2 notices from officers, directors and other affiliates planning to sell Autolus Therapeutics plc shares, newest first.

Form 144 notices for AUTL
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 2, 20263:31 PM ETPiccina CintiaOfficer6.71K$15.7KSep 2, 2026Fidelity Brokerage Services LLCSEC
Sep 16, 20245:02 PM ETMartin PuleOfficer698.7K$2.96MSep 16, 202410b5-1J.P. Morgan Securities LLCSEC